-
Thursday, 11/10/2011
A study about IL-6 response during weaning associates increasing levels of this inflammatory biomarker with Spontaneous breathing trial failure in COPD patients.
The manuscript was published in the online version of European Respiratory Journal last July 20, 2011
Further studies may corroborate the different IL-6 responses among different populations who initiate weaning, and its potential clinical implications, but in the manuscript entitled: The effect of spontaneous breathing on systemic interleukin 6 during ventilator weaning, it is clear IL-6 increases during the Spontaneous breathing trial (SBT) and that this increase is more evident in COPD patients who fail the SBT
-
Friday, 11/04/2011
Elena Prina and Valeria Giunta presented their work at the IV CIBERES Training Meeting in Mallorca
Elena Prina presented a poster about Thrombocytosis as a Diagnostic and Prognostic Marker in Community Acquired Pneumonia and Valeria Giunta presented a poster about bacterial translocation into airways during mechanical ventilation
Both Research Physicians, Elena Prina and Valeria Giunta presented their work in a poster session at the IV CIBER Training Meeting on Respiratory Diseases that was held in Mallorca last 27-28th of October.
-
Monday, 10/17/2011
"Nosocomial Pneumonia and Ventilator-Associated Pneumonia"
European Respiratory Society Monograph, Vol. 53, 2011
Nosocomial pneumonia, and particularly ventilator-associated pneumonia (VAP), is the second most frequent intra-hospital infection. The incidence of VAP has decreased in the last 5 years, from 14 to 9–10 cases per 1,000 days of mechanical ventilation. This has been an important achievement but nosocomial pneumonia and VAP still carry very high rates of morbidity and mortality and high financial costs.
-
Wednesday, 10/05/2011
New data on aetiology and prognosis of Community acquired polymicrobial pneumonia in the ICU has been published in Critical Care Journal
This study has been carried on by Catia Cilloniz and its results will be part of her Doctoral thesis directed by Prof. Antoni Torres
Clinical implications of having polymicrobial community acquired pneumonia in patients admitted to the ICU have been poorly studied. In the manuscript entitled: Community acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis, authors have studied a population of 362 patients, of which 39 had polymicrobial infections mainly due to Streptococcus pneumoniae (n=28, 72%), respiratory viruses (n=15, 39%) and Pseudomonas aeruginosa (n=8, 21%).
-
Thursday, 09/22/2011
The Gravity-VAP trial obtained official endorsement by the European Critical Care Research Network (ECCRN) of the European Society of Intensive Care Medicine
Great advantages for the Gravity-VAP trial through the endorsement by the ECCRN of the ESICM
Early in September, the Gravity-VAP trial obtained official endorsement by the European Critical Care Research Network (ECCRN) of the European Society of Intensive Care Medicine. The endorsement will facilitate, integrate and support collaborations between institutions of the Gravity-VAP Network, ultimately resulting in improved and faster patient enrollment. Additionally, the endorsement will help to broaden the interest regarding the trial within the European Community.
-
Friday, 09/02/2011
The manuscript entitled “Predictors of prolonged weaning and survival during ventilator weaning in a respiratory ICU” appears in the Top 5 Articles of the Intensive Care Medicine
Below are the 5 most-read articles on the site. This list represents the readers' preference
Predictors of prolonged weaning and survival during ventilator weaning in a respiratory ICU
Jacobo Sellares, Miquel Ferrer, Esteban Cano, Hugo Loureiro, Mauricio Valencia, Antoni Torres -
Saturday, 07/30/2011
Dr. Antoni Torres will run for Vicepresident of the European Respiratory Society (ERS)
-
Friday, 07/29/2011
Interview with Catia Cillóniz on Classification of microbial etiologies in community-acquired pneumonia by the journal publicación médica de Neumología
Cillóniz Catia is the first author of the study published in Thorax, analyzing a population of 3523 patients
The study "Microbial aetiology of community-acquired pneumonia and Its relation to severity", conducted by Catia Cillóniz and directed by Prof. Antonio Torres Martí of the research group Applied Research in Respiratory Diseases (IAMR), has been recently published in Thorax. The aim was to analyze the etiology of community-acquired pneumonia (CAP) according to the severity scores. This study signed by Cillóniz C, Ewig S, Polverino E, Marcos MA, Esquinas C, Gabarrús A, Mensa J, Torres A: "It offers an important insight with respect to each class of microorganisms and severity of the past 12 years, in a population of 3523 patients" explained this researcher in the interview conducted by the journal publicación médica de Neumología.
-
Monday, 07/18/2011
Laia Fernandez Barat awarded for the best clinical poster of the Eurobiofilms 2011 organized by European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
The event took place from the 6th to the 8th of July in Copenhagen at the Panum Institute in Denmark
Laia Fernandez Barat’s project "Confocal microscopy analysis of bacterial viability in endotracheal tube Biofilm from a pig model of MRSA pneumonia receiving antimicrobial therapy" won the best clinical poster award at the second European Congress on Microbial Biofilms- basic and clinical aspects, celebrated from the 6th to the 8th of July. This investigator, whose background is on biomedical biology, did an oral presentation on the same topic the 7th of July, in a specific symposium for Biofilm-based medical device related infections and host response.
-
Friday, 06/10/2011
Interview with Dr. Antoni Torres, a candidate for president of the Spanish Society of Pneumology and Thoracic Surgery (SEPAR)
The professor of medicine sets out the broad lines of his candidacy and future challenges for SEPAR
Interview with Dr. Antoni Torres, a candidate for President of the Spanish Society of Pneumology and Thoracic Surgery (SEPAR), setting out the broad lines of his candidacy, and the challenges that he believes that SEPAR should face in the coming years (in Spanish).